Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis

StatusWithdrawn
PhasePhase 4
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Why the trial stopped
Study closed for PI failure to submit renewal paperwork

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Terminated to Withdrawnv7
  2. Trial status: Withdrawn to Terminatedv5
  3. Trial status: Recruiting to Withdrawnv4
  4. Trial status: Not Yet Recruiting to Recruitingv2
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The purpose of this study is to determine if the combination of hydrocortisone plus fludrocortisone is more efficacious than hydrocortisone alone in treating adrenal insufficiency in severe sepsis.
Trial Details
NCT Number NCT00368381
Lead Sponsor CAMC Health System
Conditions
(from sponsor)		 Sepsis, Adrenal Insufficiency
Related terms Adrenal Insufficiency, Sepsis, Systemic Inflammatory Response Syndrome
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov